James C. Stolzenbach

1.8k citations
35 papers · 686 indexed · h-index 16

James C. Stolzenbach

35 papers receiving 655 citations

Peers

James C. Stolzenbach
Comparison fields: 5 of 71
  • Endocrinology, Diabetes and Metabolism 366
  • Surgery 465
  • Cancer Research 144
  • Pharmacology 41
  • Cardiology and Cardiovascular Medicine 93
Replace Ali Raza with:
Ali Raza United States
Donald D. Cilla United States
Inna Perevozskaya United States
Željko Reiner Croatia
Peter H. Jones United States
Paul Samuel United States
Rebecca Bakker‐Arkema United States
John Pears United Kingdom
Aditi Sapre United States
Dagny Ståhlberg Sweden
James C. Stolzenbach relative to Ali Raza United States Ali Raza's profile →
Citations per field
00.5×1.5×2.2×
Ali Raza · 1×
Citations per year

Countries citing papers authored by James C. Stolzenbach

Since Specialization
Citations

This map shows the geographic impact of James C. Stolzenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Stolzenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Stolzenbach more than expected).

Fields of papers citing papers by James C. Stolzenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Stolzenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Stolzenbach. The network helps show where James C. Stolzenbach may publish in the future.

Co-authorship network

The 25 scholars most cited alongside James C. Stolzenbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James C. Stolzenbach Line = papers co-authored together James C. Stolzenbach links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20131
2 201212
3 201112
4 201020
5 20107
6 201015
7 201015
8 201031
9 200918
10 200917
11 200858
12 200844
13 200826
14 19954
15 199534
16 19947
17 199214
18 19924
19 199112
20 19903

About James C. Stolzenbach

James C. Stolzenbach is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmaceutical Science and Surgery, having authored 35 papers that have together received 686 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Cancer, Lipids, and Metabolism (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Analytical Methods in Pharmaceuticals (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (366 citations), Surgery (465 citations) and Cancer Research (144 citations). James C. Stolzenbach has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Maureen T. Kelly, Carolyn M. Setze, Darryl J. Sleep, Susan M. Buttler, Peter H. Jones, Michael H. Davidson, Harold Bays, Dawn M. Carlson, Christie M. Ballantyne and Syed M. Mohiuddin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026